<ѻý>FDA Could Soon Limit Use of Only Drug for COVID Preventionѻý> Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns Aug 27, 2024
<ѻý>Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Careѻý> Findings from my recent study shook me to my core Aug 26, 2024
<ѻý>More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancerѻý> News, features, and commentary about cancer-related issues Aug 16, 2024
<ѻý>Novel Agent for Chronic GVHD Wins FDA Approvalѻý> Axatilimab achieved a 75% response rate in patients with previously treated chronic GVHD Aug 14, 2024
<ѻý>No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpireѻý> News, features, and commentary about cancer-related issues Aug 09, 2024
<ѻý>IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCLѻý> New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients Aug 08, 2024
<ѻý>Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Diesѻý> News, features, and commentary about cancer-related issues Aug 02, 2024
<ѻý>FDA OKs Subcutaneous Daratumumab Plus VRd for Myelomaѻý> Indicated for newly diagnosed patients who are eligible for stem cell transplant Jul 31, 2024
<ѻý>Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Riskѻý> News, features, and commentary about cancer-related issues Jul 26, 2024
<ѻý>These Athletes Weren't Doping. Their Genes Made It Look Like They Did.ѻý> Advanced sequencing revealed genetic reasons for high hemoglobin, hematocrit levels Jul 24, 2024
<ѻý>'Realistic Chance for Pregnancy' After Stem Cell Transplant, German Study Suggestsѻý> 77% of pregnancies resulted in live births Jul 19, 2024
<ѻý>Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancerѻý> News, features, and commentary about cancer-related issues Jul 19, 2024
<ѻý>Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia Aѻý> No factor VIII inhibitors developed among the 74 boys included in the study Jul 17, 2024
<ѻý>A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Tollѻý> News, features, and commentary about cancer-related issues Jul 12, 2024
<ѻý>Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapyѻý> A third of patients who had received multiple prior lines of therapy responded, small study shows Jul 10, 2024
<ѻý>Belantamab Mafodotin: The Comeback Drug in Multiple Myelomaѻý> Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials Jul 05, 2024 video
<ѻý>Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trialsѻý> News, features, and commentary about cancer-related issues Jun 28, 2024
<ѻý>Young Cervical Cancer, Leukemia Survivors at Greater Risk of Obstetric Complicationsѻý> Population-based study suggests reassurance for most, high-risk strategies for some Jun 27, 2024
<ѻý>Subcutaneous C5 Inhibitor Approved for PNHѻý> Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
<ѻý>EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancerѻý> News, features, and commentary about cancer-related issues Jun 21, 2024
<ѻý>Glofitamab Regimen Improves Survival in DLBCLѻý> Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
<ѻý>Using MRD Status to Deescalate Multiple Myeloma Therapyѻý> Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study Jun 20, 2024 video
<ѻý>Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCLѻý> High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
<ѻý>Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopeniaѻý> "Rapid and sustained" efficacy in 95% of pretreated patients in small trial Jun 19, 2024
<ѻý>Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLLѻý> Undetectable MRD rates of 90% or higher, PFS of 7 years or more Jun 17, 2024
<ѻý>New Standard of Care in High-Risk Acute Promyelocytic Leukemia?ѻý> All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard Jun 17, 2024
<ѻý>Atezolizumab Consolidation Impresses in High-Risk DLBCLѻý> Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation? Jun 14, 2024
<ѻý>Adding Isatuximab to Standard Backbone Prolongs PFS in Myelomaѻý> Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO Jun 14, 2024 video
<ѻý>Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?ѻý> News, features, and commentary about cancer-related issues Jun 13, 2024
<ѻý>New Clues to Origin of T-Cell Lymphoma After CAR-T Therapyѻý> Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
<ѻý>Brigatinib Makes Its Case for ALK-Positive ALCL in Small Studyѻý> Second-gen ALK inhibitor induces high response rate, associated with impressive survival Jun 12, 2024
<ѻý>Telomerase Inhibitor Approved for MDS-Related Anemiaѻý> Imetelstat indicated for lower-risk myelodysplastic syndromes with transfusion-dependent anemia Jun 07, 2024
<ѻý>Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapyѻý> All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years Jun 06, 2024
<ѻý>'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trialѻý> News, features, and commentary about cancer-related issues Jun 06, 2024
<ѻý>Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brainsѻý> Health news and commentary gathered by ѻý staff Jun 05, 2024
<ѻý>Triplet Notches Survival Win in Heavily Pretreated DLBCLѻý> Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant Jun 02, 2024
<ѻý>Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myelomaѻý> Second belantamab mafodotin-containing triplet to show potency in this setting Jun 02, 2024
<ѻý>Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trialѻý> Better efficacy with brentuximab vedotin versus standard chemo, substantially less toxicity Jun 01, 2024
<ѻý>Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?ѻý> News, features, and commentary about cancer-related issues May 31, 2024
<ѻý>STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CMLѻý> The benefit-risk profile could change the treatment paradigm in CML, expert says May 31, 2024